Lysosomal dysfunction results in altered energy balance
- PMID: 17911106
- DOI: 10.1074/jbc.M705124200
Lysosomal dysfunction results in altered energy balance
Abstract
The mucopolysaccharidosis (MPS) type VII mouse was originally described as the adipose storage deficiency mouse because of its extreme lean phenotype of unknown etiology. Here, we show that adipose storage deficiency and lower leptin levels are common to five different lysosomal storage diseases (LSDs): MPSI, MPSIIIB, MPSVII, Niemann-Pick type A/B, and infantile neuronal ceroid lipofuscinosis. Elevated circulating pro-inflammatory proteins (VCAM1 and MCP1) were found in multiple LSDs. Multiple anti-inflammatory strategies (dexamethasone, MCP1 deficiency, M3 expression) failed to alter adiposity in LSD animals. All of the models had normal or greater caloric intake and lower to normal metabolic rate, fasting plasma glucose, non-esterified fatty acids, cholesterol, and triglycerides. Triglycerides were lower in the livers of MPSI mice, and the trend was lower in the muscle. Lipid absorption and processing in MPSI mice were indistinguishable from those in normal mice following oral gavage of olive oil. The increased lean mass of MPSI and MPSIIIB mice suggests a shift in adipose triglycerides to lysosomal storage. In agreement, MPSI livers had a similar total caloric content but reduced caloric density, indicating a shift in energy from lipids to proteins/carbohydrates (lysosomal storage). Enzyme replacement therapy normalized the caloric density within 48 h without reducing total caloric content. This was due to an increase in lipids. Recycling of stored material is likely reduced or nonexistent. Therefore, to maintain homeostasis, energy is likely diverted to synthesis at the expense of typical energy storage depots. Thus, these diseases will serve as important tools in studying the role of lysosome function in metabolism and obesity.
Similar articles
-
A Comparative Study on the Alterations of Endocytic Pathways in Multiple Lysosomal Storage Disorders.Mol Pharm. 2016 Feb 1;13(2):357-368. doi: 10.1021/acs.molpharmaceut.5b00542. Epub 2016 Jan 11. Mol Pharm. 2016. PMID: 26702793 Free PMC article.
-
Metabolic adaptations to interrupted glycosaminoglycan recycling.J Biol Chem. 2009 Oct 23;284(43):29684-91. doi: 10.1074/jbc.M109.020818. Epub 2009 Aug 21. J Biol Chem. 2009. PMID: 19700765 Free PMC article.
-
Neuropathology in mouse models of mucopolysaccharidosis type I, IIIA and IIIB.PLoS One. 2012;7(4):e35787. doi: 10.1371/journal.pone.0035787. Epub 2012 Apr 27. PLoS One. 2012. PMID: 22558223 Free PMC article.
-
Finding pathogenic commonalities between Niemann-Pick type C and other lysosomal storage disorders: Opportunities for shared therapeutic interventions.Biochim Biophys Acta Mol Basis Dis. 2020 Oct 1;1866(10):165875. doi: 10.1016/j.bbadis.2020.165875. Epub 2020 Jun 6. Biochim Biophys Acta Mol Basis Dis. 2020. PMID: 32522631 Review.
-
Immune system irregularities in lysosomal storage disorders.Acta Neuropathol. 2008 Feb;115(2):159-74. doi: 10.1007/s00401-007-0296-4. Epub 2007 Oct 9. Acta Neuropathol. 2008. PMID: 17924126 Review.
Cited by
-
Characterization of early markers of disease in the mouse model of mucopolysaccharidosis IIIB.J Neurodev Disord. 2024 Apr 17;16(1):16. doi: 10.1186/s11689-024-09534-z. J Neurodev Disord. 2024. PMID: 38632525 Free PMC article.
-
Impact of Obesity and Lysosomal Dysfunction on Chemoresistance in Ovarian Cancer.Biomedicines. 2024 Mar 7;12(3):604. doi: 10.3390/biomedicines12030604. Biomedicines. 2024. PMID: 38540217 Free PMC article. Review.
-
The Deficiency of SCARB2/LIMP-2 Impairs Metabolism via Disrupted mTORC1-Dependent Mitochondrial OXPHOS.Int J Mol Sci. 2022 Aug 3;23(15):8634. doi: 10.3390/ijms23158634. Int J Mol Sci. 2022. PMID: 35955761 Free PMC article.
-
Altered protein secretion in Batten disease.Dis Model Mech. 2021 Dec 1;14(12):dmm049152. doi: 10.1242/dmm.049152. Epub 2021 Dec 6. Dis Model Mech. 2021. PMID: 34870700 Free PMC article. Review.
-
Enzyme Replacement Therapy Can Reverse Pathogenic Cascade in Pompe Disease.Mol Ther Methods Clin Dev. 2020 Jun 10;18:199-214. doi: 10.1016/j.omtm.2020.05.026. eCollection 2020 Sep 11. Mol Ther Methods Clin Dev. 2020. PMID: 32671132 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Molecular Biology Databases
Miscellaneous